These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 8062156

  • 21. A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.
    Thiébaud D, Jaeger P, Gobelet C, Jacquet AF, Burckhardt P.
    Am J Med; 1988 Aug; 85(2):207-12. PubMed ID: 3261129
    [Abstract] [Full Text] [Related]

  • 22. [Characteristic changes in serum phosphomonoesterase isoenzymes in Paget's disease. (6. Thin layer electrophoresis of "phosphatases")].
    Maruna RF.
    Wien Klin Wochenschr; 1970 Mar 20; 82(12):225-6. PubMed ID: 5439282
    [No Abstract] [Full Text] [Related]

  • 23. Inflammatory cytokines in Paget's disease of bone.
    Werner de Castro GR, Buss Z, Da Rosa JS, Fröde TS.
    Int Immunopharmacol; 2014 Feb 20; 18(2):277-81. PubMed ID: 24355795
    [Abstract] [Full Text] [Related]

  • 24. Plasma calcitonin in Paget's disease of bone.
    Kanis JA, Heynen G, Walton RJ.
    Clin Sci Mol Med; 1977 Mar 20; 52(3):329-32. PubMed ID: 844263
    [Abstract] [Full Text] [Related]

  • 25. Influence of pharmacological doses of calcitonin on serum beta 2 microglobulin concentration.
    Mulder H, van Bolhuis H, Naafs MA, Winckers PL.
    Calcif Tissue Int; 1985 Jul 20; 37(4):367-71. PubMed ID: 3930032
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A heterogeneity in serum osteocalcin N-terminal fragments in Paget's disease: a comparison with other biochemical indices in pre- and postmenopause.
    Gorai I, Hosoda K, Chaki O, Taguchi Y, Nakayama M, Yoh K, Yamaji T, Minaguchi H.
    Calcif Tissue Int; 1998 Dec 20; 63(6):459-65. PubMed ID: 9817938
    [Abstract] [Full Text] [Related]

  • 33. Clinical utility of a wheat-germ precipitation assay for determination of bone alkaline phosphatase concentrations in patients with different metabolic bone diseases.
    Braga V, Dorizzi R, Brocco G, Rossini M, Zamberlan N, Gatti D, Adami S.
    Eur J Clin Chem Clin Biochem; 1995 Jul 20; 33(7):433-9. PubMed ID: 7548450
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
    Torres R, de la Piedra C, Rapado A.
    Scand J Clin Lab Invest; 1989 May 20; 49(3):279-85. PubMed ID: 2787049
    [Abstract] [Full Text] [Related]

  • 36. Beta 2-microglobulin in postmenopausal osteoporosis.
    Rico H, Ripoll E, Revilla M, Relea P, Villa LF.
    Calcif Tissue Int; 1993 Aug 20; 53(2):78-80. PubMed ID: 8402325
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.